Grants and Contracts Details
Description
LThe mission of the CFFT Therapeutics Development Network is to facilitate the clinical study of new and existing
therapies to cure and control cystic fibrosis and to improve the quality oflife of patients with CF. The goals of the
TDC network include the following:
• Protect the safety and rights of individuals with CF involved in clinical research;
• Optimize patient access to clinical trials of therapeutic approaches throughout the United States;
• Optimize the benefit of clinical research for the CF community by creating a centralized process for
coordinating and prioritizing trials;
• Maintain specialized centers of excellence for early and late stage study design and development, consultation
with industry, core laboratory procedures, and interpretation of specialized data;
• Utilize pooled resources (e.g., data, specimens, etc.) to pose new questions regarding the pathophysiology of
CF and to develop new therapeutic approaches and biomarkers; and
• Maximize the efficient use of resources for study development and conduct by maintaining specialized centers
for the conduct of early phase clinical trials, facilitating training and mentoring of clinical research staff, and
developing best practices for clinical research through continuous quality improvement processes.
Status | Finished |
---|---|
Effective start/end date | 1/1/09 → 12/31/09 |
Funding
- Cystic Fibrosis Foundation: $86,923.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.